Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization

Timothy Y. Y. Lai, Franklin Luk, G K Y Lee, Dennis S.C. Lam

Eye · 2012 · 101 citations · 35 references

DOIFull text

Open access

Concepts

References

35